Truist Securities analyst Michael Swartz maintains Polaris (NYSE:PII) with a Hold and lowers the price target from $115 to $105.
What Does AstraZeneca’s Debt Look Like?
Over the past three months, shares of AstraZeneca Inc. (NASDAQ:AZN) moved higher by 7.38%. When understanding a companies…